All In Biotech

Drug Trial Radar · NCT06126497

Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

An Open-Label Study Evaluating the Safety and Efficacy of Ropanicant in Participants With Moderate to Severe Major Depressive Disorder

Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

41

Actual

Start

Feb 5, 2024

Primary completion

Jul 19, 2024

Study completion Jul 19, 2024

Sponsor

Lead sponsor
Suven Life Sciences LimitedIndustry
Sponsor type
Industry
First posted
Nov 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, parallel-group study to evaluate the safety and efficacy of Ropanicant in participants with moderate to severe Major Depressive Disorder (MDD).

Conditions

  • Major Depressive Disorder

Interventions

  • RopanicantDrug

    Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-Emergent Adverse EventsTime frame: From Screening to Day 21

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Innovations, Inc

    Bellflower, California

  • NRC Research Institute

    Orange, California

  • Collaborative Neuroscience Research, LLC

    Torrance, California

  • Innovative Clinical Research, Inc.

    Miami Lakes, Florida

  • CenExel iResearch, LLC

    Decatur, Georgia

  • CenExel iResearch, LLC

    Savannah, Georgia

  • Precise Research Centers

    Flowood, Mississippi

  • Neuro behavioral Clinical Research, Inc

    North Canton, Ohio

  • Cedar Clinical Research, Inc.

    Murray, Utah

  • Eastside Therapeutic Resource, Inc. dba Core Clinical Research

    Everett, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.